Delivery Order SPE2DB20D3104-SPE2DB21FV7U0
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $1,037.15 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide pharmaceutical products and medical supplies. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through November 2026. The contract covers a wide range of medical commodities,...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $1,132.63 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide a wide range of pharmaceutical products and medical supplies. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The contract covers the delivery of specialty medications,...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of medical products. The $1,679.08 firm fixed-price contract has a period of performance through January 21, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC enables the DLA to...
- The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a Delivery Order contract valued at $5,111.65 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. This contract is a task order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, worth up to $999,999,999.00 through December 2025. The contract is for the supply of pharmaceutical products and medical supplies, including specialty, brand name, generic, and...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for $12,138.54 to provide a wide range of pharmaceutical products and medical supplies. This contract is a task order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical division. The contract covers the delivery of specialty...
- The U.S. government's Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for $1,560.48. The contract is a firm fixed price agreement for the delivery of various pharmaceutical products and medical supplies to support military healthcare programs. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $2,297.75 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999, covers the delivery of a variety of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract includes specialty medications,...
- The U.S. government's Defense Logistics Agency (DLA) awarded a $7,357.18 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract, with a completion date of February 11, 2025, is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,515.16 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of a wide range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,535.46 to Amerisourcebergen Drug Corp, a division of the parent company Cencora, Inc. The contract is for the provision of pharmaceutical and medical products to support military healthcare programs. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB21FV7U0Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,564.63 to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the provision of pharmaceutical and medical products. This contract is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 and running through November 2026. The contract encompasses a wide range of essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition. Amerisourcebergen's extensive supply chain and distribution capabilities make it a critical vendor for the DLA and other federal agencies in providing pharmaceutical and medical supplies to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 5/18/21 |